Primary endpoints met in ALLY-1 trial evaluating a daclatasvir-based regimen in HCV

Press/Media: Press / Media

PeriodApr 28 2015

Media coverage

1

Media coverage

  • TitlePrimary endpoints met in ALLY-1 trial evaluating a daclatasvir-based regimen in HCV
    Media name/outletCPhI.cn
    CountryChina
    Date4/28/15
    PersonsFred Poordad